Montelukast Prescribing at THORNDIKE PARTNERSHIP
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
1,500
Total Quantity
47.7K
NHS Cost
£2.4K
vs National Avg
+119.1%
THORNDIKE PARTNERSHIP prescribed 1,500 items of Montelukast over the last 12 months at a cost of £2,354 to the NHS. This is 119.1% above the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jul 2026
130
Jul 2026
126
Jul 2026
132
Jul 2026
120
Jul 2026
104
Jul 2026
148
Jul 2026
116
Jul 2026
127
Jul 2026
142
Jul 2026
120
Jul 2026
123
Jul 2026
112
Prescribing Details
| Total Items | 1,500 |
|---|---|
| Total Quantity | 47,684 |
| Total NHS Cost | £2,354 |
| Presentations | 4 different forms |
| vs National Average | +119.1% |
Montelukast Prescribing Comparison
| This practice | 1,500 items |
|---|---|
| National average per practice | 685 items |
| Difference | +119.1% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.